Clinical Trials Logo

Brain Injuries, Traumatic clinical trials

View clinical trials related to Brain Injuries, Traumatic.

Filter by:

NCT ID: NCT04854954 Completed - Clinical trials for Traumatic Brain Injury

Prediction of Secondary Neurological Deterioration in Patients With Moderate Traumatic Brain Injury

PREDICT-TCM
Start date: February 3, 2021
Phase:
Study type: Observational

Patients with moderate traumatic brain injury (mTBI) are 1,5 times more frequent than those with severe TBI and some of them will develop secondary neurologic deterioration (SND) within the first 7 days. However, identifying at risk patients of SND is still challenging. This study aimed to determine risk factors associated with SND after mTBI.

NCT ID: NCT04849221 Completed - Clinical trials for Intracranial Pressure

Wideband Tympanometry for Monitoring Intracranial Pressure in Adult Patients in Intensive Care, Operated on for an Intracranial Lesion After Traumatic Brain Injury, or With Intracranial Hemorrhage

TYMPIC
Start date: March 4, 2021
Phase:
Study type: Observational

Intracranial pressure is usually measured by invasive methods requiring an intracranial sensor. There is no non-invasive monitoring method recognized as a gold standard. Tympanometry would make it feasible to evaluate intracranial pressure through sensitive and specific changes in the energy absorbance of the middle ear. It could represent a non-invasive method of monitoring intracranial pressure. This is a prospective monocentric longitudinal study. All adult patients in intensive care for head trauma, intracranial hypertension, or after cranial surgery and requiring invasive monitoring of ICP will be included after their non-opposition has been collected. In a group of 10 controls, multifrequency tympanometry will be performed in the standing position, in the 0° supine position and in the Tredelenburg position at -17°.

NCT ID: NCT04836481 Completed - Clinical trials for Traumatic Brain Injury

A Pharmacokinetic Analysis of Levetiracetam Prophylaxis in Critically Ill Patients With Severe Traumatic Brain Injury

Start date: January 1, 2021
Phase:
Study type: Observational

This study aims is to describe the pharmacokinetic properties of levetiracetam through measurement of serum concentrations in critically ill, severe traumatic brain injury patients.

NCT ID: NCT04833218 Active, not recruiting - Clinical trials for Traumatic Brain Injury

Propranolol Versus Propranolol and Clonidine in Sympathetic Hyperactivity After Moderate Traumatic Brain Injury

Start date: January 31, 2020
Phase: Early Phase 1
Study type: Interventional

evaluation of the effect of Propranolol versus propranolol and clonidine on decreasing sympathetic hyperactivity after moderate traumatic brain injury

NCT ID: NCT04826068 Completed - Clinical trials for Traumatic Brain Injury

Emotional Processing Intervention for Children With TBI

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

Investigating an emotional processing program, that is modified for use with children, is effective for children with a traumatic brain injury (TBI).

NCT ID: NCT04823507 Completed - Clinical trials for Mild Traumatic Brain Injury

Photobiomodulation for Concussions: the Use of the ImPACT® Test as an Assessment Tool

Start date: March 26, 2021
Phase:
Study type: Observational

Brain photobiomodulation (PBM) therapy is an innovative modality for the stimulation of neural activity in order to improve brain function and is currently under investigation as a treatment for several diverse neurological disorders. Our emphasis on this study is to review the use of PBM as a treatment modality for concussions and the use of ImPACT® (Immediate Post-Concussion Assessment and Cognitive Testing) test to assess improvement in cognition and symptomatology in patients with post-concussion syndrome (PCS) treated with PBM.

NCT ID: NCT04820881 Recruiting - Clinical trials for Neurodegenerative Diseases

Cerebrovascular Reactivity and Oxygen Metabolism as Markers of Neurodegeneration After Traumatic Brain Injury

Start date: October 1, 2021
Phase:
Study type: Observational

This grant award entitled, "Cerebrovascular Reactivity and Oxygen Metabolism as Markers for Neurodegeneration after Traumatic Brain Injury" (hereafter, "Neurovascular Study"), aims to determine if neurovascular contributors to neurodegeneration can serve as markers of the emergence or progression of degenerative processes after traumatic brain injury in middle-aged and older adults.

NCT ID: NCT04820634 Recruiting - Clinical trials for Traumatic Brain Injury

Using Virtual Reality to Improve Job Reentry in Adults With TBI

Start date: December 12, 2019
Phase: N/A
Study type: Interventional

The purpose of this research is to investigate the effectiveness of virtual reality (VR) to improve job reentry skills in individuals with TBI.

NCT ID: NCT04815967 Active, not recruiting - Multiple Sclerosis Clinical Trials

Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity

Start date: November 16, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

Phase 2/3, randomized, double-blind, placebo-controlled, single-treatment, multicenter trial assessing the efficacy and safety of MYOBLOC for the treatment of upper limb spasticity in adults followed by an open-label extension safety trial.

NCT ID: NCT04810442 Recruiting - Clinical trials for Traumatic Brain Injury

Investigating How Sleep After Training Can Affect the Learning of a Motor Skill in Individuals With Brain Injury

Start date: February 18, 2020
Phase: N/A
Study type: Interventional

Studies have shown that a period of sleep, even in the form of a daytime nap, after a period of training on a motor learning task can boost subsequent performance beyond that observed after an equal amount of time spent awake and resting. This leap in performance has been referred to as "off-line" motor learning because it occurs during a period of sleep in the absence of additional practice. Motor learning is an integral part of the physical and occupational therapy that patients receive after traumatic brain injury (TBI) in which various activities of daily living may need to be relearned. Targeted motor skills may include dressing (learning how to zip up a jacket or button a shirt), using a fork and knife to eat, or using technology (tapping touch screen on a cell phone or typing on a computer). Yet the potential of sleep in the form of a strategic nap as a therapeutic tool to maximize motor learning in rehabilitation therapies has not been fully realized. In addition, a growing body of research among healthy individuals has shown evidence of changes in the brain associated with enhanced performance among those who slept following training compared with those who spent the same amount of time awake. The neural mechanisms of "off-line" motor learning have not been studied among individuals with TBI. Using functional neuroimaging and measurement of brain waves, the current study will examine the mechanisms underlying this sleep-related enhancement of motor learning among individuals with TBI and determine how brain physiology may influence the magnitude of the effect. By understanding how this treatment works and identifying the factors that modulate its effectiveness we can identify which individuals will be most likely to benefit from a nap after training to improve motor learning after TBI. This can provide a more person-centered approach to treatment delivery that can maximize the effectiveness of a simple but potent behavioral intervention.